In This Store
Nanjing Finetech Chemical is a company responding to the demand of registered starting material and intermediates from new drug development to the drug already on the market with our certain quality assurance and variegated technology.
located in Nanjing High-tech Development Zone, with 2000sqms lab, more than 50 R&D chemists and 98 sets of fume hoods, the analytical research center is equipped with HPLC, GC, LC-MS, GC-MS, H-NMR to make sure fast response to the research requests.
2.Wholly owned GMP manufacturing site (Anhui Finetech Pharma Co.,Ltd.)
located in Chuzhou dingyuan Chemical Park, two hours by car to Nanjing.total 50,000sqms composed with two multi-purpose plants,one hydrogenation plant.one D class cleanroom and one analytical research center, kinds of analytical equipment are in place, with which secure quality control is implemented.
3.Equipments
In the plant We have 3-4reactors in one room to avoid material cross-contamination physically,each reactor adopts a temperature automatic control system (TCU), temperature and pressure signal access to DCS, connect each dangerous process reactor into SIS system; automatic scraper discharge centrifuge and horizontal centrifuge equipped with online oxygen detection&nitrogen protection and online automatic cleaning system; drying equipment using double cone dryer and vacuum oven to meet the needs of closed production,each drying equipment is set in an independent room, avoiding cross-contamination and material mixing. All production and storage areas are equipped with automatic alarm detectors and exhaust fans.
4.Technology platform
In this site We can fulfill high pressure hydrogenation(10mpa),high pressure ammoniation(9mpa), oxidation, bromination,high Vacuum distillation(-0.1mpa), azido reaction,diazo reaction,chlorination ,grignard reaction ,ultra-low temperature -80℃ and high temperature 280℃.
Product range
Indacaterol RSM&intermediates
Formoterol RSM&intermediates
Baloxavir RSM&intermediates
Tofacitinib RSM&intermediates
Cabozantinib RSM&intermediates
Olmutinib RSM&intermediates
Obeticholic Acid RSM&intermediates
Tianeptine acid RSM&intermediates
Atropine RSM&intermediates
Sorafenib RSM&intermediates
And other small molecules for new drug development
Year of Establishment: 2007
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: 100-500
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Small Orders Accepted
Other Competitive Advantages:
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: